Posted August 20, 2016

Smart Lipo Weight Loss Supplement Found to Contain Undeclared Drugs

On June 16, 2016, the FDA issued a warning letter to Centro Naturista because the company's weight loss supplement, Smart Lipo, was found to contain undeclared sibutramine and phenolphthalein.

Sibutramine, the active ingredient in the obesity d rug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.

Phenolphthalein, once an ingredient in some over-the-counter laxative products, was reclassified by the FDA in 1999 as "not generally recognized as safe and effective."

In addition, statements made about Smart Lipo on the product label, such as "Burns Fat," and "Suppresses Appetite" were found to be drug claims.

See ConsumerLab.com's Review of Weight Loss Supplements for tests of related products.

See Related Warnings:

"Super Herbs" Weight Loss Supplement Recalled

Ultimate Herbal Slimcaps Recalled

"Natureal" Weight Supplement Recalled

Weight and Enhancement Supplement Recall Expanded

Weight Supplement Found to Contain Drug

Five Weight Loss Supplements Recalled

Weight Loss Supplement Contains Hidden Drug

FDA Warns of Weight Loss Supplement Dangers

Recall of "Bee Pollen" Supplement Found to Contain Drug

FDA Warns Consumers of Weight Loss and Body Reshaping Supplements Containing Controlled Substance

For more about the recall, use the link below.